Austin Miller, PhD
Statistician
Gynecologic Oncology Group
GOG SDC
Elm and Carlton Streets
Buffalo,
NY
USA
14263
Papers:
2 - Scientific Plenary
A randomized phase III trial of gemcitabine + docetaxel + bevacizumab or placebo as first-line treatment for metastatic uterine leiomyosarcoma (uLMS): a Gynecologic Oncology Group study
41 - Featured Poster
The impact and interaction of preoperative disease burden, complex surgery, and residual disease in patients with advanced stage ovarian cancer and the effect on on patient survival: A GOG 182 analysis
60 - Scientific Plenary
Predictive model for preoperative determination of microscopic residual disease at the time of primary cytoreduction in patients with advanced-stage epithelial ovarian cancer: a Gynecologic Oncology Group (GOG) 182 analysis
169 - Poster Session A
Oxaliplatin is a safe alternative therapeutic option for patients with recurrent gynecologic cancers following hypersensitivity reaction to carboplatin
237 - Poster Session A
Clinicopathologic benchmark for prognostic modeling of advanced epithelial ovarian cancer long-term survival: a Gynecologic Oncology Group (GOG) analysis